E2F1 and laryngotracheoesophageal cleft: The rs3213172C/T polymorphism of the E2F1 gene can be used as an effective biomarker for the genetic susceptibility of LC in the Chinese population [25].Therefore, the selected core targets can not only be used as markers of LC but may also become one of the key targets for the treatment of LC.